Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • Federal Reserve presses ahead with quarter-point rate rise despite banking turmoil
    • Ukraine hit by drone attacks as Russia accuses Kyiv of targeting Crimea
    • ECB president warns of danger of ‘tit-for-tat’ inflation
    • Xi Jinping backs Vladimir Putin on Ukraine but holds out on Russian gas pipeline
    • Emmanuel Macron holds firm on pensions reform amid protests
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Companies
      Sections
      • Companies Home
      • Banks in turmoil
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
      Most Read
      • Swiss regulator defends $17bn wipeout of AT1 bonds in Credit Suisse deal
      • US bondholders prepare to sue Swiss government over $17bn Credit Suisse wipeout
      • What the takeover of Credit Suisse means for UBS
      • British billionaire Jim Ratcliffe plans to offer more than £5bn for Manchester United
      • Bank shares slide as Janet Yellen plays down ‘blanket’ deposit guarantee
    • Tech
    • Markets
      Sections
      • Markets Home
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
      Most Read
      • Swiss regulator defends $17bn wipeout of AT1 bonds in Credit Suisse deal
      • US bondholders prepare to sue Swiss government over $17bn Credit Suisse wipeout
      • Live news updates from March 22: Fed raises rates 25 bps, UK inflation hits 10.4%
      • Live news: Pound and gilt yields edge higher after BoE rate decision
      • Bank shares slide as Janet Yellen plays down ‘blanket’ deposit guarantee
    • Climate
    • Opinion
      Sections
      • Opinion Home
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
      Most Read
      • A hefty shock awaits those who see little difference between Starmer and Sunak
      • It’s unwise to get Trump on a technicality
      • EY, KPMG and the fallout of two accounting scandals
      • Risk of ‘industrial capture’ looms over AI revolution
      • Beware the ‘sensible’ crypto crowd — they’re worse than the fanatics
    • Work & Careers
      Sections
      • Work & Careers Home
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      Most Read
      • From SVB to the BBC: why did no one see the crisis coming?
      • Football’s first female super-agent Rafaela Pimenta on dealmaking and discrimination
      • Social media content moderators lead charge for better rights
    • Life & Arts
      Sections
      • Life & Arts Home
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
      Most Read
      • Everything I, an Italian, thought I knew about Italian food is wrong
      • The bleak beauty of Death Valley
      • Succession Season 4 puts the Roys on the brink of battle royal — review
      • Pack away the Peloton — Daylesford owner launches luxury health club
      • Bring on the near-misses to avoid the financial meltdowns
    • HTSI
    MenuSearch
    • Home
    • World
    • US
    • Companies
    • Tech
    • Markets
    • Climate
    • Opinion
    • Work & Careers
    • Life & Arts
    • HTSI
    Financial Times
    SubscribeSign In

    Martin Shkreli

    Add to myFT Digest

    Add this topic to your myFT Digest for news straight to your inbox

    • Wednesday, 1 August, 2018
      David Crow
      Trump is losing the war on drug prices

      The US needs a health secretary with the mettle to enact painful industry reforms

    • Friday, 9 March, 2018
      US & Canadian companies
      ‘Pharma bro’ Shkreli sentenced to seven years in jail

      Biotech entrepreneur convicted of fraud breaks down in court and says he was ‘young and immature’

    • Monday, 5 March, 2018
      Pharmaceuticals sector
      Judge orders Martin Shkreli to forfeit $7.36m in assets

      Ruling after fraud conviction includes Picasso and ultra-rare Wu-Tang Clan album

    • Thursday, 4 January, 2018
      US & Canadian companies
      Cost of Viagra soars as hundreds of drug prices rise in US

      Pfizer among those risking backlash with new year increases on many medicines

    • Thursday, 14 December, 2017
      FT AlphavillePaul Murphy
      Markets Live: Thursday, 14th December, 2017
    • Friday, 1 December, 2017
      FT AlphavilleAlexandra Scaggs
      Attn Wu-Tang Clan fans
    • Thursday, 14 September, 2017
      US & Canadian companies
      Martin Shkreli sent to jail over Hillary Clinton hair post

      Pharma entrepreneur had offered $5,000 to anyone who could ‘grab a hair’ from her head

    • Wednesday, 13 September, 2017
      Pharmaceuticals sector
      Martin Shkreli sent to jail after Clinton hair post

      Bail revoked after ‘pattern of threats and harassment’

    • Wednesday, 13 September, 2017
      World
      Martin Shkreli sent to jail after Clinton hair post
    • Thursday, 7 September, 2017
      World
      Martin Shkreli’s Wu-Tang Clan album bids near $1m
    • Wednesday, 23 August, 2017
      News in-depthFT Alphaville
      Shkreli self-owns like a boss
    • Friday, 4 August, 2017
      Pharmaceuticals sector
      Martin Shkreli found guilty on three counts of fraud

      Brash biotech entrepreneur could face years in prison when sentenced

    • Friday, 4 August, 2017
      World
      Martin Shkreli convicted of securities fraud
    • Wednesday, 26 July, 2017
      FT AlphavilleDavid Keohane
      Further reading
    • Friday, 7 July, 2017
      Jonathan Guthrie
      Mike Ashley’s tragic flaw is ineptitude, not booze

      The Sports Direct founder’s antics offer a pop psychologist a lifetime’s material

    • Wednesday, 28 June, 2017
      US & Canadian companies
      Martin Shkreli on trial: genius or conman?

      Lawyer says former pharma executive’s ‘strange’ ways do not mean he is guilty

    • Tuesday, 27 June, 2017
      US & Canadian companies
      Martin Shkreli’s ‘very evil’ reputation hinders jury selection

      Court weeds through 250 New Yorkers as some are excused due to strong views

    • Sunday, 25 June, 2017
      US & Canadian companies
      Drug price gouger Shkreli goes on trial for fraud

      Prosecutors allege he ran hedge fund as though it were a ‘Ponzi-like’ scheme

    • Friday, 23 June, 2017
      Bank stress tests
      Week ahead: ‘Pharma Bro’ on trial, Fed stress tests II, Nike results
    • Thursday, 18 May, 2017
      FT AlphavillePaul Murphy
      “He’s 32 and worth $100mil, he’s living the American dream”
    • Thursday, 18 May, 2017
      Pharmaceuticals sector
      Fact-checking the Martin Shkreli musical

      A play about the pharmaceutical executive has opened in New York

    • Friday, 12 May, 2017
      FT AlphavilleDavid Keohane
      Further reading
    • Thursday, 10 November, 2016
      News in-depthUS presidential election
      Donald Trump’s victory gives US drugmakers a tonic

      Shares rise as fears of crackdown on pricing subside after Clinton election defeat

    • Thursday, 3 November, 2016
      Lunch with the FT
      Lunch with the FT: Can Martin Shkreli defend corporate greed?

      The entrepreneur on failed friendships and why his fraud trial is ‘all for political show’

    • Wednesday, 28 September, 2016
      FT AlphavilleDavid Keohane
      Further reading
    Previous page You are on page 1 Next page

    Useful links

    Support

    View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

    Legal & Privacy

    Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

    Services

    Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT ChannelsSecondary Schools

    Tools

    PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

    Community & Events

    FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

    More from the FT Group

    Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
    The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
    Financial Times

    International Edition

    Subscribe for full access
    • Switch to UK Edition

    Top sections

    • Home
    • World
      • Global Economy
      • UK
      • US
      • China
      • Africa
      • Asia Pacific
      • Emerging Markets
      • Europe
      • War in Ukraine
      • Americas
      • Middle East & North Africa
      • Australia & NZ
    • US
      • US Economy
      • US Companies
      • US Politics & Policy
    • Companies
      • Banks in turmoil
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
    • Tech
    • Markets
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
    • Climate
    • Opinion
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
    • Work & Careers
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
    • Life & Arts
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
    • Personal Finance
      • Property & Mortgages
      • Investments
      • Pensions
      • Tax
      • Banking & Savings
      • Advice & Comment
      • Next Act
    • HTSI
    • Special Reports

    FT recommends

    • Lex
    • Alphaville
    • Lunch with the FT
    • FT Globetrotter
    • #techAsia
    • Moral Money
    • FTfm
    • Newsletters
    • Video
    • Podcasts
    • News feed
    • FT Live Events
    • FT Forums
    • Board Director Programme
    • myFT
    • Portfolio
    • Today's Newspaper (ePaper)
    • Crossword
    • Our Apps
    • Help Centre
    • Subscribe
    • Sign In